STOCK TITAN

Alpha Tau Medical Ltd - DRTS STOCK NEWS

Welcome to our dedicated news page for Alpha Tau Medical (Ticker: DRTS), a resource for investors and traders seeking the latest updates and insights on Alpha Tau Medical.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Alpha Tau Medical's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Alpha Tau Medical's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.42%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.79%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.68%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.52%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.61%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.31%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.28%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.54%
Tags
conferences
Alpha Tau Medical Ltd

Nasdaq:DRTS

DRTS Rankings

DRTS Stock Data

196.47M
51.74M
25.72%
2.74%
0.08%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
Israel
Jerusalem

About DRTS

alpha tau medical (http://www.alphataumedical.com/) focuses on research, development and commercialization of alpha dart (diffusing alpha-emitters radiation therapy) for the treatment of solid cancer tumors. alpha dart technology, initially developed at tel aviv university, was shown to be effective and safe for treating different types of cancer in multiple animal studies. the company is running its first clinical trial in several sites in the eu. breakthrough technology for cancer treatment the alpha dart breakthrough technology utilizes alpha radiation to treat cancer and enables highly potent and conformal radiotherapy. alpha dart treats solid tumors with interstitial radioactive seeds that continually release short-lived alpha emitting atoms into the tumor.